gnrh agonist trigger versus hcg trigger in gnrh antagonist in ivf/icsi cycles: a review article
نویسندگان
چکیده
routinely, a bolus of 5.000-10.000 iu human chorionic gonadotropin (hcg) is usedfor the final follicular maturation and ovulation as a standard method. hcg has thesame effect of luteinizing hormone (lh) with long half-life. it has the longlutheotrophic effect which increases the risk of ovarian hyper stimulation syndrome(ohss). recently, gonadotropin-releasing hormone agonist (gnrh-a) trigger hasbeen used for the induction of final follicular maturation and ovulation with the aimof reducing the ohss risk. several studies have shown that the releases ofendogenous follicular stimulating hormone (fsh) and lh after administration ofgnrh agonist in in vitro fertilization (ivf) cycles are able to precede the finalfollicular maturation leading to removal of fertile oocyte with normal developmentof the embryo and ultimately pregnancy. but based on the results of some studies,using gnrh-a trigger leads to defect luteal-phase resulting to reduce theimplantation and clinical pregnancy rates and also increase abortion in fresh embryotransfer cycles compared to routine ivf cycle with hcg triggering . also, in recentyears, studies have continued to modify the luteal phase support, so that the freshembryo transfer is possible too. in this review, we examined the benefits, problems,and also ways to reform gnrh agonist triggering complications
منابع مشابه
GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article
Routinely, a bolus of 5.000-10.000 IU human chorionic gonadotropin (hCG) is used for the final follicular maturation and ovulation as a standard method. HCG has the same effect of luteinizing hormone (LH) with long half-life. It has the long lutheotrophic effect which increases the risk of ovarian hyper stimulation syndrome (OHSS). Recently, gonadotropin-releasing hormone agonist (GnRH-a) trigg...
متن کاملNew Perspectives on Criteria for the Determination of HCG Trigger Timing in GnRH Antagonist Cycles
The aim of this study was to investigate 2 quantification criteria to evaluate the developmental condition of follicles cohort and clarify their impacts upon the determining of human chorionic gonadotropin trigger timing and the reproductive outcome: the proportion of mature follicles in growing follicles cohort on the day of human chorionic gonadotropin trigger and the peak estradiol level per...
متن کاملGnRH agonist and GnRH antagonist in intracytoplasmic injection cycles.
The long agonistic protocol for controlled ovarian hyperstimulation (COH) is effective and used most often, thus is considered the gold standard. Therefore any new regimen has to be compared in its results with those obtained with the long protocol. This report compares the efficacy of GnRH agonist and antagonist in a retrospective study of IVF/ICSI carried out in a tertiary teaching hospital f...
متن کاملMicrodose GnRH Agonist Flare-Up versus Ultrashort GnRH Agonist Combined with Fixed GnRH Antagonist in Poor Responders of Assisted Reproductive Techniques Cycles
متن کامل
GnRH agonist versus GnRH antagonist in oocyte donation cycles: a prospective randomized study.
BACKGROUND The specific role of LH in folliculogenesis and oocyte maturation is unclear. GnRH antagonists, when administered in the late follicular phase, induce a sharp decrease in serum LH which may be detrimental for IVF outcome. This study was performed to evaluate whether the replacement of GnRH agonist (triptorelin) by a GnRH antagonist (ganirelix; NV Organon) in oocyte donation cycles ha...
متن کاملGnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology
BACKGROUND The selection of developmentally competent human gametes may increase the efficiency of assisted reproduction. Spermatozoa and oocytes are usually assessed according to morphological criteria. Oocyte morphology can be affected by the age, genetic characteristics, and factors related to controlled ovarian stimulation. However, there is a lack of evidence in the literature concerning t...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
international journal of reproductive biomedicineجلد ۱۴، شماره ۹، صفحات ۵۵۷-۰
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023